161 related articles for article (PubMed ID: 8425213)
41. Small amounts of superantigen, when presented on dendritic cells, are sufficient to initiate T cell responses.
Bhardwaj N; Young JW; Nisanian AJ; Baggers J; Steinman RM
J Exp Med; 1993 Aug; 178(2):633-42. PubMed ID: 8340760
[TBL] [Abstract][Full Text] [Related]
42. Rejection of an IA+ variant line of FBL-3 leukemia by cytotoxic T lymphocytes with CD4+ and CD4-CD8- T cell receptor-alpha beta phenotypes generated in CD8-depleted C57BL/6 mice.
Yoshimura A; Shiku H; Nakayama E
J Immunol; 1993 Jun; 150(11):4900-10. PubMed ID: 8496592
[TBL] [Abstract][Full Text] [Related]
43. MHC-specific recognition of a bacterial superantigen by weakly reactive T cells.
Surman S; Deckhut AM; Blackman MA; Woodland DL
J Immunol; 1994 May; 152(10):4893-902. PubMed ID: 8176210
[TBL] [Abstract][Full Text] [Related]
44. Antibody-targeted superantigens induce lysis of major histocompatibility complex class II-negative T-cell leukemia lines.
Ihle J; Holzer U; Krull F; Dohlsten M; Kalland T; Niethammer D; Dannecker GE
Cancer Res; 1995 Feb; 55(3):623-8. PubMed ID: 7530598
[TBL] [Abstract][Full Text] [Related]
45. Suppression of immune responses by CD8 cells. I. Superantigen-activated CD8 cells induce unidirectional Fas-mediated apoptosis of antigen-activated CD4 cells.
Noble A; Pestano GA; Cantor H
J Immunol; 1998 Jan; 160(2):559-65. PubMed ID: 9551888
[TBL] [Abstract][Full Text] [Related]
46. Human major histocompatibility complex class II-negative colon carcinoma cells present staphylococcal superantigens to cytotoxic T lymphocytes: evidence for a novel enterotoxin receptor.
Dohlsten M; Hedlund G; Segren S; Lando PA; Herrmann T; Kelly AP; Kalland T
Eur J Immunol; 1991 May; 21(5):1229-33. PubMed ID: 1645269
[TBL] [Abstract][Full Text] [Related]
47. Highly lytic CD8+, alpha beta T-cell receptor cytotoxic T cells with major histocompatibility complex (MHC) class I antigen-directed cytotoxicity in beta 2-microglobulin, MHC class I-deficient mice.
Apasov S; Sitkovsky M
Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2837-41. PubMed ID: 8464897
[TBL] [Abstract][Full Text] [Related]
48. T cell response to embryonal carcinoma F9 cells: induction and characterization of T cell receptor alpha beta+ double-negative cytotoxic T lymphocytes.
Imada M; Fujimoto S
Jpn J Cancer Res; 1993 Jan; 84(1):58-64. PubMed ID: 8095495
[TBL] [Abstract][Full Text] [Related]
49. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.
Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Stathopoulos GP; Papamichail M
Cancer; 1994 Aug; 74(4):1275-82. PubMed ID: 7914469
[TBL] [Abstract][Full Text] [Related]
50. Staphylococcal-enterotoxin-dependent cell-mediated cytotoxicity.
Dohlsten M; Hedlund G; Kalland T
Immunol Today; 1991 May; 12(5):147-50. PubMed ID: 1878125
[TBL] [Abstract][Full Text] [Related]
51. Clonal analysis of in vivo activated CD8+ cytotoxic T lymphocytes from a melanoma patient responsive to active specific immunotherapy.
Kan-Mitchell J; Huang XQ; Steinman L; Oksenberg JR; Harel W; Parker JW; Goedegebuure PS; Darrow TL; Mitchell MS
Cancer Immunol Immunother; 1993 Jul; 37(1):15-25. PubMed ID: 8513449
[TBL] [Abstract][Full Text] [Related]
52. Vbeta-restricted T cell adherence to endothelial cells: a mechanism for superantigen-dependent vascular injury.
Brogan PA; Shah V; Klein N; Dillon MJ
Arthritis Rheum; 2004 Feb; 50(2):589-97. PubMed ID: 14872503
[TBL] [Abstract][Full Text] [Related]
53. Superantigenic staphylococcal exotoxins induce T-cell proliferation in the presence of Langerhans cells or class II-bearing keratinocytes and stimulate keratinocytes to produce T-cell-activating cytokines.
Tokura Y; Yagi J; O'Malley M; Lewis JM; Takigawa M; Edelson RL; Tigelaar RE
J Invest Dermatol; 1994 Jan; 102(1):31-8. PubMed ID: 8288908
[TBL] [Abstract][Full Text] [Related]
54. T-cell immunotherapy for human MK-1-expressing tumors using a fusion protein of the superantigen SEA and anti-MK-1 scFv antibody.
Ueno A; Arakawa F; Abe H; Matsumoto H; Kudo T; Asano R; Tsumoto K; Kumagai I; Kuroki M; Kuroki M
Anticancer Res; 2002; 22(2A):769-76. PubMed ID: 12014649
[TBL] [Abstract][Full Text] [Related]
55. Functional characterization of the interaction between the superantigen staphylococcal enterotoxin A and the TCR.
Antonsson P; Wingren AG; Hansson J; Kalland T; Varga M; Dohlsten M
J Immunol; 1997 May; 158(9):4245-51. PubMed ID: 9126986
[TBL] [Abstract][Full Text] [Related]
56. Superantigen-mediated cellular cytotoxicity is dependent on antigen expression, but independent of the P-glycoprotein multidrug resistance phenotype.
Zehrer C; Beck J; Gekeler V; Ihle J; Holzer U; Dohlsten M; Kalland T; Niethammer D; Dannecker GE
Br J Haematol; 1996 Dec; 95(3):452-6. PubMed ID: 8943883
[TBL] [Abstract][Full Text] [Related]
57. Endothelial cells expressing an inflammatory phenotype are lysed by superantigen-targeted cytotoxic T cells.
Riesbeck K; Billström A; Tordsson J; Brodin T; Kristensson K; Dohlsten M
Clin Diagn Lab Immunol; 1998 Sep; 5(5):675-82. PubMed ID: 9729535
[TBL] [Abstract][Full Text] [Related]
58. Staphylococcal enterotoxin-A directly stimulates signal transduction and interferon-gamma production in psoriatic T-cell lines.
Nielsen MB; Odum N; Gerwien J; Svejgaard A; Bendtzen K; Bregentholt S; Röpke C; Geisler C; Dohlsten M; Kaltoft K
Tissue Antigens; 1998 Dec; 52(6):530-8. PubMed ID: 9894851
[TBL] [Abstract][Full Text] [Related]
59. Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) can regulate dendritic cell-induced activation and cytotoxicity of CD8(+) T cells independently of CD4(+) T cell help.
McCoy KD; Hermans IF; Fraser JH; Le Gros G; Ronchese F
J Exp Med; 1999 Apr; 189(7):1157-62. PubMed ID: 10190907
[TBL] [Abstract][Full Text] [Related]
60. Superantigen-induced human CD4+ helper/killer T cell phenomenon. Selective induction of Th1 helper/killer T cells and application to tumor immunotherapy.
Kuge S; Miura Y; Nakamura Y; Mitomi T; Habu S; Nishimura T
J Immunol; 1995 Feb; 154(4):1777-85. PubMed ID: 7836762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
